IP Library › Granted Patent US 7,838,700
Granted Patent B2
US 7,838,700 · App. 10/495,359 · Granted Nov 23, 2010

Recovery and recycling of chiral tartaric acid resolving agents

Assignee: Aesica Pharmaceuticals
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,838,700
App. No.
10/495,359
Granted
Nov 23, 2010
Kind
B2
Abstract

A process for the recovery of substituted tartaric acid resolving agents from resolution process liquors comprising organic solvents, wherein the substituted tartaric acid derivatives are neutralised by adding a base, extracted into an aqueous phase and crystallized from the aqueous phase by addition of a mineral acid in the presence of an organic solvent.

Claims (14)

1. A process for recovering a substituted tartaric acid resolving agent from a resolution process liquor,

wherein the resolution process liquor comprises an organic solvent, and a substituted tartaric acid resolving agent of the formula:

said process comprising:

A) adding a base to the resolution process liquor to neutralize the substituted tartaric acid resolving agent;

B) extracting the liquor obtained in A) into an aqueous phase; and

C) adding a mineral acid and a water soluble or partly water soluble organic co-solvent to the aqueous phase obtained in B) to crystallize a substituted tartaric acid resolving agent from the aqueous phase.

2. A process according to claim 1 wherein the substituted tartaric acid resolving agent is chosen from (+)-di-O,O′-toluoyl-(D)-tartaric acid, (−)-di-O,O′-toluoyl-(L)-tartaric acid, (+)-di-O,O′-benzoyl-(D)-tartaric acid, or (−)-di-O,O′-benzoyl-(L)-tartaric acid.

3. A process according to claim 1 wherein the base is added as an aqueous solution.

4. A process according to claim 1 wherein the substituted tartaric acid resolving agent is neutralized by a hydroxide, carbonate or hydrogen carbonate salt of an alkali or alkaline earth metal or ammonia.

5. A process according to claim 1 wherein the organic co-solvent is a C 1 to 10 -alcohol.

6. A process according to claim 1 wherein the organic co-solvent is 2-butanol.

7. A process according to claim 1 wherein the mineral acid is hydrochloric acid, hydrobromic acid, or sulfuric acid.

8. A process according to claim 1 wherein the mineral acid is hydrochloric acid.

9. A process according to claim 1 wherein the substituted tartaric acid resolving agent is crystallised in the form of a solvate with the co-solvent.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2005
From: BASF AKTIENGESELLSCHAFT
To: AESICA PHARMACEUTICALS
Reel/Frame 016711/0139 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2004
From: MARTIN, STEVE; PIERGENTILI, DANIELE
To: BASF AKTIENGESELLSCHAFT
Reel/Frame 015852/0780 →
Priority Claims (1)
GB 0127346.5 · Nov 14, 2001 · national
Continuity (1)
Related Publication 20050085665A1 · Apr 21, 2005